BG RESEARCH

Updated 27 days ago
Private Limited Company
  • Active - 05105594 (CH)
  • Age: 19 years
  • ID: 3478700/151
5 The Business Centre Harvard Way Kimbolton Huntingdon PE28 0NJ United Kingdom
• 72190 - Other research and experimental development on natural sciences and engineering
Innovation is the driving force behind everything we do at BG Research; it is deeply embedded in our company culture and DNA. We seek what is new and novel, redefine conventional approaches and view challenges from a unique perspective. With a portfolio of IP, and over 25 years of qPCR experience, knowledge as well as innovative engineering and cutting-edge technologies, BG Research is well equipped to tackle the most challenging diagnostic problems. We are passionate about harnessing our innovations to further improve healthcare and health outcomes for both human and veterinary applications... BG Research is dedicated to supporting the technology led actionable strategy of At Patient Testing (APT) - true point of care testing in any environment... We specialise In Vitro Diagnostics (IVDs) which use RT-qPCR to detect genetic material. This involves the development, validation and manufacturing of platform technologies compromising of the instrumentation and reagent system. Our goal..
Also known as: B G RESEARCH LIMITED, BG Research Ltd, BioGene
Registration numbers: 02800327 (W), 05105594 (CH)
VAT numbers: GB576854584, GB850142068
Primary location: Huntingdon United Kingdom
  • 0
  • 0
Interest Score
3
HIT Score
0.60

UK Company Data

Company number
05105594
Account category
TOTAL EXEMPTION FULL
Account ref. day
30
Account ref. month
4
Accounts next due date
2025-01-31
Accounts last made up date
2023-04-30
Returns next due date
2017-05-17
Returns last made up date
2016-04-19
Num. mort. charges
1
Num. mort. outstanding
1
Num. mort. part. satisfied
0
Num. mort. satisfied
0
Num. gen. partners
0
Num. lim. partners
0
Domain
bgresearchltd.com

Actual
www.bgresearchltd.com

IP
104.21.62.165, 172.67.137.137

Status
OK

Category
Company
0 comments Add a comment